Winner’s lead therapy targets Parkinson’s disease; platform addresses 6,000+ genetic disorders Neoclease gains access to Merck’s technologies and expert support to scale its AI-designed gene-editing ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback